ARTICLE | Company News
Immune Design, AstraZeneca deal
November 1, 2010 7:00 AM UTC
Immune Design granted AstraZeneca's MedImmune LLC subsidiary exclusive, worldwide rights to develop and commercialize its glucopyranosyl lipid adjuvant (GLA) as a component in vaccines for undisclose...